Skip to content

600062.SH

华润双鹤

SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN

CNY 15.83
+1.02%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue10.7B11.0B11.2B11.3B9.6B
Cost of Revenue4.6B4.6B4.8B4.9B4.3B
Gross Profit6.2B6.4B6.4B6.4B5.3B
Operating Expenses
R&D Expense526.7M531.6M555.2M627.8M482.5M
SG&A Expense
General & Admin Expense960.9M966.9M961.0M872.3M752.1M
Selling & Marketing Expense2.9B3.1B3.2B3.1B2.7B
Other Expenses
Total Operating Expenses4.6B4.7B4.8B4.7B4.0B
Cost and Expenses9.1B9.3B9.6B9.5B8.3B
Operating Income (EBIT)1.8B1.9B1.8B1.9B1.4B
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)1.9B1.9B1.9B1.9B1.4B
Income Tax Expense193.7M227.5M215.9M272.7M201.3M
Bottom Line
Net Income1.6B1.6B1.6B1.7B1.2B
Earnings from Cont. Ops1.7B1.7B1.7B1.7B1.2B
Earnings from Discont. Ops
Bottom Line Net Income1.6B1.6B1.6B1.7B1.2B
Per Share
Basic EPSCN¥1.58CN¥1.59CN¥1.58CN¥1.63CN¥1.14
Diluted EPSCN¥1.58CN¥1.59CN¥1.58CN¥1.63CN¥1.14
Revenue Per ShareCN¥10.39CN¥10.65CN¥10.91CN¥11.04CN¥9.30
Shares
Basic Shares Outstanding1.0B1.0B1.0B1.0B1.0B
Diluted Shares Outstanding1.0B1.0B1.0B1.0B1.0B
Profitability Metrics
EBITDA2.6B2.6B2.6B2.0B
D&A771.6M734.9M669.8M544.3M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026